NanHua Bio-medicine Co., Ltd

000504.SZ

000504.SZNanHua Bio-medicine Co., Ltd

Shenzhen

7.29

CNY

-0.14

(-1.88%)

-0.09EPS

-81.00P/E

2.41BMarket Cap

May 23Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

CNE000000263

Return %

Stock

S&P500

-34.32

26.76

-67.91

25.48

-19.54

87.24

Use logarithmic scale

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	0.3	0.25	0.08	0.06	0.04	0.22	0.22	0.3	0.43	0.65	0.49	0.64	0.44	0.37
Basic EPS, GAAP	-0.1	-0.48	0.04	-0.08	-0.07	0.07	-0.12	-0.11	0.06	0.03	-0.06	-0.04	-0.09	-0.08
Free Cash Flow per Basic Share	-0.01	-0.01	-0.1	-0.1	-0.1	-0.06	-0.16	-0.08	0.04	-0.78	0.24	0.48	0.1	-0.02
Dividend per Share	- -	- -	- -	- -	0.01	0.01	0.03	0.03	0.04	- -	0.01	0.01	0.01	0.02
Book Value per Share	0.16	-0.33	-0.26	-0.35	-0.45	-0.37	-0.49	-0.58	-0.54	-0.59	-0.56	-0.61	-0.64	-0.64
Tangible Book Value per Share	-0.16	-0.16	-0.05	-0.03	-0.1	0.15	0.32	0.12	0.32	0.45	0.32	0.23	0.97	0.88
Basic Weighted Avg Shares	299	311	345	327	303	311	309	320	313	272	319	311	313	330
Sales/Revenue/Turnover	91	77	26	18	13	67	67	95	134	176	157	200	137	123
Operating Margin (%)	-9.72	7.44	-73.08	-95.49	-135.53	-9.03	-39.9	-13.7	-3.82	13.92	2.55	6.09	-6.62	-11.91
Depreciation Expense	1	1	1	5	5	4	2	5	6	3	7	6	6	- -
Net Income, GAAP	-30	-149	14	-26	-21	22	-37	-35	19	8	-19	-12	-28	-28
Effective Tax Rate (%)	- -	- -	39.49	- -	- -	11.96	- -	- -	- -	22.84	- -	- -	- -	6.61
Profit Margin (%)	-32.9	-194.27	52.52	-142.34	-158.65	32.35	-55.08	-36.89	14.02	4.64	-12.21	-6.22	-20.6	-22.49
Working Capital	-70	-51	-67	-62	-75	-40	-14	-80	-6	59	-12	-39	202	198
LT Debt	1	1	1	1	1	1	20	1	1	19	17	15	13	11
Total Equity	130	-21	4	7	-15	80	128	108	114	134	110	80	305	293
Return on Invested Capital (%)	- -	- -	- -	- -	- -	-5.91	- -	- -	- -	11.02	- -	- -	- -	- -
Return on Capital (%)	- -	- -	-16.37	- -	- -	259.44	- -	- -	- -	-24.94	- -	- -	- -	-79.9
Return on Common Equity (%)	-48.57	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	44.42%	11.39%	-31.72%
Net Income, GAAP	-124%	-90.67%	126.15%
Free Cash Flow	-208.29%	-427.36%	-79.69%
Total Cash Common Dividend	- -	8.44%	-4.69%
Total Equity	-55.61%	51.68%	279.96%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Changqiao You
Full Time Employees: 512
Sector: Healthcare
Industry: Biotechnology
Address: Caixin Building Changsha People's Republic of China 410205
IPO Date: Invalid Date
Website: www.nhbiogroup.com
Business: NanHua Bio-medicine Co., Ltd. provides stem and immune cell storage, noninvasive genetic testing, and biological research and technical services. The company is based in Changsha, China.

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	0.3	0.25	0.08	0.06	0.04	0.22	0.22	0.3	0.43	0.65	0.49	0.64	0.44	0.37
Basic EPS, GAAP	-0.1	-0.48	0.04	-0.08	-0.07	0.07	-0.12	-0.11	0.06	0.03	-0.06	-0.04	-0.09	-0.08
Free Cash Flow per Basic Share	-0.01	-0.01	-0.1	-0.1	-0.1	-0.06	-0.16	-0.08	0.04	-0.78	0.24	0.48	0.1	-0.02
Dividend per Share	- -	- -	- -	- -	0.01	0.01	0.03	0.03	0.04	- -	0.01	0.01	0.01	0.02
Book Value per Share	0.16	-0.33	-0.26	-0.35	-0.45	-0.37	-0.49	-0.58	-0.54	-0.59	-0.56	-0.61	-0.64	-0.64
Tangible Book Value per Share	-0.16	-0.16	-0.05	-0.03	-0.1	0.15	0.32	0.12	0.32	0.45	0.32	0.23	0.97	0.88
Basic Weighted Avg Shares	299	311	345	327	303	311	309	320	313	272	319	311	313	330
Sales/Revenue/Turnover	91	77	26	18	13	67	67	95	134	176	157	200	137	123
Operating Margin (%)	-9.72	7.44	-73.08	-95.49	-135.53	-9.03	-39.9	-13.7	-3.82	13.92	2.55	6.09	-6.62	-11.91
Depreciation Expense	1	1	1	5	5	4	2	5	6	3	7	6	6	- -
Net Income, GAAP	-30	-149	14	-26	-21	22	-37	-35	19	8	-19	-12	-28	-28
Effective Tax Rate (%)	- -	- -	39.49	- -	- -	11.96	- -	- -	- -	22.84	- -	- -	- -	6.61
Profit Margin (%)	-32.9	-194.27	52.52	-142.34	-158.65	32.35	-55.08	-36.89	14.02	4.64	-12.21	-6.22	-20.6	-22.49
Working Capital	-70	-51	-67	-62	-75	-40	-14	-80	-6	59	-12	-39	202	198
LT Debt	1	1	1	1	1	1	20	1	1	19	17	15	13	11
Total Equity	130	-21	4	7	-15	80	128	108	114	134	110	80	305	293
Return on Invested Capital (%)	- -	- -	- -	- -	- -	-5.91	- -	- -	- -	11.02	- -	- -	- -	- -
Return on Capital (%)	- -	- -	-16.37	- -	- -	259.44	- -	- -	- -	-24.94	- -	- -	- -	-79.9
Return on Common Equity (%)	-48.57	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

	Dec'23	Mar'24	Jun'24
Total Current Assets	655	498	472
Accounts Receivable, Net	123	124	125
Cash, Cash Equivalents & STI	496	313	307
Inventories	11	14	18
Total Current Liabilities	452	294	275
Payables & Accruals	- -	- -	- -
ST Debt	31	28	3
Deferred Revenue	- -	- -	- -

NanHua Bio-medicine Co., Ltd

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Quarterly Earnings Per Share

Year

Capital Structure

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year

Working Capital

Year	Q1	Q2	Q3	Q4	FY
2022	- -	- -	- -	- -	-0.04
2023	-0.01	- -	- -	- -	-0.09
2024	-0.01	- -	- -	- -	- -

	Dec'23	Mar'24	Jun'24
ST Debt	31	28	3
LT Borrowings	- -	- -	- -
LT Finance Leases	13	14	11
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	330	330	330
Market Capitalization	3,638	2,853	2,276